233 related articles for article (PubMed ID: 21880508)
1. Intended use of reference products & WHO International Standards/Reference Reagents in the development of similar biological products (biosimilars).
Thorpe R; Wadhwa M
Biologicals; 2011 Sep; 39(5):262-5. PubMed ID: 21880508
[TBL] [Abstract][Full Text] [Related]
2. WHO expert committee on specifications for pharmaceutical preparations.
World Health Organization
World Health Organ Tech Rep Ser; 2013; (981):i-xi, 1-188. PubMed ID: 23821930
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of similar biotherapeutic products: scientific and regulatory challenges.
Griffiths E; Thorpe R; Wadhwa M; Sohn Y
Biologicals; 2011 Sep; 39(5):249. PubMed ID: 21925898
[No Abstract] [Full Text] [Related]
4. Summary of the diverse situation of similar biotherapeutic products in the selected countries (August 2010).
Kang HN
Biologicals; 2011 Sep; 39(5):304-7. PubMed ID: 21880507
[TBL] [Abstract][Full Text] [Related]
5. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
World Health Organization
World Health Organ Tech Rep Ser; 2012; (970):1-235, back cover. PubMed ID: 22894011
[TBL] [Abstract][Full Text] [Related]
6. WHO expert committee on specifications for pharmaceutical preparations. Fortieth report.
WHO Expert Committee on Specifications for Pharmaceutical Preparations
World Health Organ Tech Rep Ser; 2006; 937():1-461, back cover. PubMed ID: 16836287
[TBL] [Abstract][Full Text] [Related]
7. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
World Health Organization
World Health Organ Tech Rep Ser; 2005; 929():1-142, backcover. PubMed ID: 16353684
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of similar biotherapeutic products (SBPs): scientific principles and their implementation.
Knezevic I
Biologicals; 2011 Sep; 39(5):256-61. PubMed ID: 21907589
[TBL] [Abstract][Full Text] [Related]
9. China's perspective on similar biotherapeutic products.
Liang C; Wang J
Biologicals; 2011 Sep; 39(5):312-6. PubMed ID: 21924622
[TBL] [Abstract][Full Text] [Related]
10. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
World Health Organ Tech Rep Ser; 2008; (948):1-138. PubMed ID: 18557474
[TBL] [Abstract][Full Text] [Related]
11. WHO Expert Committee on specifications for pharmaceutical preparations.
World Health Organ Tech Rep Ser; 1996; 863():1-194. PubMed ID: 8952445
[TBL] [Abstract][Full Text] [Related]
12. Regulatory guidelines for biosimilars in Malaysia.
Abas A
Biologicals; 2011 Sep; 39(5):339-42. PubMed ID: 21784655
[TBL] [Abstract][Full Text] [Related]
13. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Forty-first report.
World Health Organization
World Health Organ Tech Rep Ser; 2007; (943):1-156. PubMed ID: 17621973
[TBL] [Abstract][Full Text] [Related]
14. Current development in regulation of similar biotherapeutic products in Brazil.
Castanheira LG; Barbano DB; Rech N
Biologicals; 2011 Sep; 39(5):308-11. PubMed ID: 21868247
[TBL] [Abstract][Full Text] [Related]
15. The regulatory framework for similar biotherapeutic products in Cuba.
Hechavarría Núñez Y; Pérez Massipe RO; Orta Hernández SD; Muñoz LM; Jacobo Casanueva OL; Pérez Rodríguez V; Domínguez Morales RB; Pérez Cristiá RB
Biologicals; 2011 Sep; 39(5):317-20. PubMed ID: 21930393
[TBL] [Abstract][Full Text] [Related]
16. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
World Health Organ Tech Rep Ser; 1999; 885():i-vi, 1-156. PubMed ID: 10352573
[TBL] [Abstract][Full Text] [Related]
17. Current regulatory and scientific considerations for approving biosimilars in Iran.
Hadavand N; Valadkhani M; Zarbakhsh A
Biologicals; 2011 Sep; 39(5):325-7. PubMed ID: 21873077
[TBL] [Abstract][Full Text] [Related]
18. Regulatory guideline for biosimilar products in Korea.
Suh SK; Park Y
Biologicals; 2011 Sep; 39(5):336-8. PubMed ID: 21784653
[TBL] [Abstract][Full Text] [Related]
19. Concept of biosimilar products in Jordan.
Haddadin RD
Biologicals; 2011 Sep; 39(5):333-5. PubMed ID: 21873079
[TBL] [Abstract][Full Text] [Related]
20. Biosimilars and non-innovator biotherapeutics in India: an overview of the current situation.
Malhotra H
Biologicals; 2011 Sep; 39(5):321-4. PubMed ID: 21784652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
